{"id":751454,"date":"2023-04-26T11:17:53","date_gmt":"2023-04-26T15:17:53","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/prosomnus-announces-q1-2023-investor-call-and-participation-in-upcoming-investor-conferences\/"},"modified":"2023-04-26T11:17:53","modified_gmt":"2023-04-26T15:17:53","slug":"prosomnus-announces-q1-2023-investor-call-and-participation-in-upcoming-investor-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/prosomnus-announces-q1-2023-investor-call-and-participation-in-upcoming-investor-conferences\/","title":{"rendered":"ProSomnus Announces Q1 2023 Investor Call and Participation in Upcoming Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">PLEASANTON, Calif., April  26, 2023  (GLOBE NEWSWIRE) &#8212; ProSomnus, Inc.\u00a0(\u201cthe Company\u201d) (NASDAQ:\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=A35794D8gyUqGcN155pbd3lr6O7XqzFTIP-16S_b2u3LCS7Ch3-8yR88ACFGFEkse6Z4J-l4lE_58p6pYBgZS3TyuKUVcy7fjx15W0K4d0WeSXL_3pNYumAsI4wzwqRIOXDlaA1-IuiUntXFs9JENwVmt-HN5qqwWAZlXRTbG-4-VGE64FD6wK-993KsBkB0vIghv1iNn3Pc_IeARLUijDODpsPi_94uyxCE_fGwHxA=\" rel=\"nofollow noopener\" target=\"_blank\">OSA<\/a>), a pioneer in precision medical devices for the treatment of Obstructive Sleep Apnea (OSA), will report its first quarter financial results after market close on Thursday, May 9, 2023. ProSomnus Chief Executive Officer,\u00a0Len Liptak, and Chief Financial Officer,\u00a0Brian Dow, will host a conference call that day at\u00a01:30 p.m. PT\u00a0\/\u00a04:30 p.m. ET\u00a0to discuss the reported results and provide a business update.<\/p>\n<p>\n        <strong>Investor Call Dial-In Information<\/strong>\n      <\/p>\n<p>Interested parties may register for the conference call using the following link: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=aBMgJ32omM6RzHQY6BRTcVXDMVb6OUfiUGP5-XyC8lgqP__fWavP6MGyLlMnhLsPHYx4vm38t3tiagHrjcD4Q_VRAt8OFL6NaT1g7fm5YsU1-zfI3P7JppCTDxirJL8dcTkfLWh3I8x5Hsig4Em1GS1zLCAoxHX4pZC4Gq4jYBvRWe4Kv_LqPwQvVuhf0EiT\" rel=\"nofollow noopener\" target=\"_blank\">ProSomnus Q1 Earnings Registration Link<\/a><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=dEFExk7Ua-9BH-sG_BuA2wUbz1bGp8ExSb5DvwnRE8ip2d6TeeQbVX0d1zlmTcdAvDd-C2xCKc7LCkqJZvZeOL3lYXeSmYlUjqjX487MUjlgf_9HNcXu-1JG32BI_dVo\" rel=\"nofollow noopener\" target=\"_blank\">.<\/a> You may access the live webcast of the conference call by using the following link:\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=aBMgJ32omM6RzHQY6BRTcVXDMVb6OUfiUGP5-XyC8lhq-hSCtH8aMsd1mobgnYetPnE68shbSyv4IxZapT4BlP5Iy5_lgGmOXvnqS_KNGsddY7z47XJmxtNOYd9Ynkxf\" rel=\"nofollow noopener\" target=\"_blank\">ProSomnus Q1 Earnings Call<\/a>. The link will also be posted in the Investor Relations section of the ProSomnus website at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=vBtDV5dc9ymKZhvZB3U1GTZcn-mILsaPZ8z5MJ4bJ7RLO3rw6ZCAj6wvKTKEp04pHO8_8t3UEMSXwKYrBUB9ICFlBaXYcepnVP2qHyrOC5Jpyv745UR0K8mYezjWq_jgnxFMSTPyJSVCMEIV4dYBzniINzGqfHSQwONhKEjF5ZRBMU30VW1ewjMsygaZzym1hOdM-1GeW2YwstuuIMj1MYKsbmMHP54NiSKb8gRk7zBvfaW3fnplXAY-EjlYe1OrqTe3rovqnPSTWyQcQkJChj5ODmgquauDhCgjJe81Vc8=\" rel=\"nofollow noopener\" target=\"_blank\">News &amp; Events<\/a>.<\/p>\n<p>\n        <strong>Upcoming Investor Conferences<\/strong>\n      <\/p>\n<p>The Company also announces the participation in two upcoming conferences in May 2023:<\/p>\n<ul type=\"disc\">\n<li style=\"margin-bottom:8pt\">Inaugural EF Hutton Global Conference<\/li>\n<li style=\"margin-bottom:8pt\">20<sup>th<\/sup> Annual Craig Hallum Institutional Investor Conference<\/li>\n<\/ul>\n<p>\n        <strong>About Inaugural EF Hutton Global Conference<\/strong>\n      <\/p>\n<p>ProSomnus\u2019 Chief Executive Officer,\u00a0Len Liptak, and Chief Financial Officer,\u00a0Brian Dow, will engage in investor 1&#215;1 meetings during the EF Hutton Global Conference on May 10, 2023 at the Plaza Hotel in New York, New York.<\/p>\n<p>\n        <strong>About 20th Annual Craig-<\/strong><br \/>\n        <strong>Hallum<\/strong><br \/>\n        <strong> Institutional Investor Conference <\/strong>\n      <\/p>\n<p>ProSomnus\u2019 Chief Executive Officer,\u00a0Len Liptak, and Chief Financial Officer,\u00a0Brian Dow, will engage in investor 1&#215;1 meetings during the\u00a0Craig-Hallum Annual Conference on May 31, 2023 at the Depot Renaissance Minneapolis Hotel.<\/p>\n<p>\n        <strong>About <\/strong><br \/>\n        <strong>ProSomnus<\/strong><br \/>\n        <br \/>ProSomnus (NASDAQ: OSA) precision intraoral medical devices offer effective, economical, and patient-preferred treatment for patients suffering from Obstructive Sleep Apnea (OSA). ProSomnus is the first manufacturer of mass-customized Precision Oral Appliance Therapy (OAT) devices to treat OSA, which affects over 74 million people in\u00a0North America\u00a0and is associated with serious comorbidities, including heart failure, stroke, hypertension, morbid obesity, and type 2 diabetes. ProSomnus\u2019s patented, FDA-cleared devices are a less invasive and more comfortable alternative to Continuous Positive Airway Pressure (CPAP) therapy, and lead to effective and patient-preferred outcomes. A growing body of research, including studies published by the\u00a0Journal of Clinical Sleep Medicine\u00a0and\u00a0Military Medicine, suggests ProSomnus\u2019s Precision OAT devices are an effective treatment for mild to moderate OSA. Additional clinical research has shown that ProSomnus\u2019s Precision OAT devices mitigate many of the side effects associated with alternative treatments and improve economics for payers and providers. With more than 200,000 devices delivered, ProSomnus\u2019s devices are the most prescribed Precision OAT in the\u00a0U.S.\u00a0ProSomnus\u2019s FDA-cleared devices are authorized by the\u00a0Department of Defense\u00a0and the\u00a0U.S. Army, and are often covered by medical insurance, Medicare, and social health programs in key international markets. To learn more, visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=rKeyzccH4gFrmZkTCiFGL8nsrhqSsweb30ySrmiuUAvkNmVOude9X9HfYRwFj-OpJ4AOmdRVBekIboSO4Q6gDOYQC09uXh46l1ZjG0A9oFQdWZ7e3wXH3PfoHZaQI7Z1JkQaFObMfi6ZjRPTjJoZL5nJi78eGxe-hL_FKamqk9BdlAA2EpJdou92uj0eZxz1Zij4J3KT_dpTyxzSh3k90peFfusYBvHDL1A3DS1J_-04dSdiGVml79WqSJWmfFqOya78WFZlC0CPYVtDwWhRHmaUjl_NGHwcuNlXuE1wAwQCSc4RoWwTA1SpgQFqPN9MPMeF3j7kjjwf5gjTnYeugGvVtaLSYsJ9ua7zAFmLTmmUmSbNBurYzSAG7-bB0Owo-NG5oWDR9iXtvoJv2Ki-p2YvmEQs88drLNaQcDmN6Vs=\" rel=\"nofollow noopener\" target=\"_blank\">www.ProSomnus.com<\/a>.<\/p>\n<p>\n        <strong>Investor<\/strong><br \/>\n        <strong>Contact<\/strong><br \/>\n        <br \/>Mike Cavanaugh<br \/>ICR Westwicke<br \/>Phone: +1.617.877.9641<br \/>Email:\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=oUzGYob3h3T61OqNhuHic3RMXpzMspXMWdVJKXkeb6XCZFxl45rnJZHieToqAwpuuUugc6k9ZV3lJDU87tDNtgKiVnOTQl9Mrku1aLmTxPBoDSr2-_EPLHQwBWOoYU0c264joQGG4KQQMC9KPZGzjwsUjKepZpZapbn_8M5IR3UefVU53SmjgdW091dE9ZN7K8xu5Ptb-EaMFZ5usGC1NH5iJKsxbH8yBdQZ0HsmpvLR7bNURFPC5NsyP0mR8Qj2XWxd0Q6wusnfV82BUSKuRGlrLLaP2fk8JpzSc17KE4M=\" rel=\"nofollow noopener\" target=\"_blank\">Mike.Cavanaugh@westwicke.com<\/a><\/p>\n<p>\n        <strong>Media Contact<\/strong><br \/>\n        <br \/>Elizabeth Coleman<br \/>ICR Westwicke<br \/>Phone: +1.203.682.4783<br \/>Email:\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=xwwFbPeRrzvcGHsa3rmHO-w6LM05JigySy8bxVrh92cqN8Z9l-Mq2CZj04AvtoC7go1Gum1fcC7OW0mGeEKVyIOeFsXafsgd9_VoYVBefIuwhPDCwq_P6vBEsfuhbq3NzMpDPP9ptZIy7ti3IranQ2n8Z7EzBKqVpLCWqnv_G0z0PZf7HXD1ecQNLAbultfLdfbMWp3WGeYKSSblML8lmgO6e7YsXRMvO5vtzEPo3GLvEzsHUSxwlYeF3Ar-pJEqqTLZAn_4p1jsyL8Etxkwdfh3NIZvmQ2eM6gB6IB_FeRjIIXMKkMLTkK4VfNC2Xx_\" rel=\"nofollow noopener\" target=\"_blank\">Elizabeth.Coleman@westwicke.com<\/a><\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyNTUzMCM1NTU3MTgzIzIyNDQ3MTE=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/OTQ3NjU5MmYtOWM2ZS00NzY0LWJjZmMtMDkwYjI4NDM5NWUzLTEyNTYyNjQ=\/tiny\/ProSomnus-Sleep-Technologies-I.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>PLEASANTON, Calif., April 26, 2023 (GLOBE NEWSWIRE) &#8212; ProSomnus, Inc.\u00a0(\u201cthe Company\u201d) (NASDAQ:\u00a0OSA), a pioneer in precision medical devices for the treatment of Obstructive Sleep Apnea (OSA), will report its first quarter financial results after market close on Thursday, May 9, 2023. ProSomnus Chief Executive Officer,\u00a0Len Liptak, and Chief Financial Officer,\u00a0Brian Dow, will host a conference call that day at\u00a01:30 p.m. PT\u00a0\/\u00a04:30 p.m. ET\u00a0to discuss the reported results and provide a business update. Investor Call Dial-In Information Interested parties may register for the conference call using the following link: ProSomnus Q1 Earnings Registration Link. You may access the live webcast of the conference call by using the following link:\u00a0ProSomnus Q1 Earnings Call. The link will also be posted in the Investor &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/prosomnus-announces-q1-2023-investor-call-and-participation-in-upcoming-investor-conferences\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;ProSomnus Announces Q1 2023 Investor Call and Participation in Upcoming Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-751454","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ProSomnus Announces Q1 2023 Investor Call and Participation in Upcoming Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/prosomnus-announces-q1-2023-investor-call-and-participation-in-upcoming-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ProSomnus Announces Q1 2023 Investor Call and Participation in Upcoming Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PLEASANTON, Calif., April 26, 2023 (GLOBE NEWSWIRE) &#8212; ProSomnus, Inc.\u00a0(\u201cthe Company\u201d) (NASDAQ:\u00a0OSA), a pioneer in precision medical devices for the treatment of Obstructive Sleep Apnea (OSA), will report its first quarter financial results after market close on Thursday, May 9, 2023. ProSomnus Chief Executive Officer,\u00a0Len Liptak, and Chief Financial Officer,\u00a0Brian Dow, will host a conference call that day at\u00a01:30 p.m. PT\u00a0\/\u00a04:30 p.m. ET\u00a0to discuss the reported results and provide a business update. Investor Call Dial-In Information Interested parties may register for the conference call using the following link: ProSomnus Q1 Earnings Registration Link. You may access the live webcast of the conference call by using the following link:\u00a0ProSomnus Q1 Earnings Call. The link will also be posted in the Investor &hellip; Continue reading &quot;ProSomnus Announces Q1 2023 Investor Call and Participation in Upcoming Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/prosomnus-announces-q1-2023-investor-call-and-participation-in-upcoming-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-04-26T15:17:53+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyNTUzMCM1NTU3MTgzIzIyNDQ3MTE=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prosomnus-announces-q1-2023-investor-call-and-participation-in-upcoming-investor-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prosomnus-announces-q1-2023-investor-call-and-participation-in-upcoming-investor-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"ProSomnus Announces Q1 2023 Investor Call and Participation in Upcoming Investor Conferences\",\"datePublished\":\"2023-04-26T15:17:53+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prosomnus-announces-q1-2023-investor-call-and-participation-in-upcoming-investor-conferences\\\/\"},\"wordCount\":480,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prosomnus-announces-q1-2023-investor-call-and-participation-in-upcoming-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgyNTUzMCM1NTU3MTgzIzIyNDQ3MTE=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prosomnus-announces-q1-2023-investor-call-and-participation-in-upcoming-investor-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prosomnus-announces-q1-2023-investor-call-and-participation-in-upcoming-investor-conferences\\\/\",\"name\":\"ProSomnus Announces Q1 2023 Investor Call and Participation in Upcoming Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prosomnus-announces-q1-2023-investor-call-and-participation-in-upcoming-investor-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prosomnus-announces-q1-2023-investor-call-and-participation-in-upcoming-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgyNTUzMCM1NTU3MTgzIzIyNDQ3MTE=\",\"datePublished\":\"2023-04-26T15:17:53+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prosomnus-announces-q1-2023-investor-call-and-participation-in-upcoming-investor-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prosomnus-announces-q1-2023-investor-call-and-participation-in-upcoming-investor-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prosomnus-announces-q1-2023-investor-call-and-participation-in-upcoming-investor-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgyNTUzMCM1NTU3MTgzIzIyNDQ3MTE=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgyNTUzMCM1NTU3MTgzIzIyNDQ3MTE=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prosomnus-announces-q1-2023-investor-call-and-participation-in-upcoming-investor-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ProSomnus Announces Q1 2023 Investor Call and Participation in Upcoming Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ProSomnus Announces Q1 2023 Investor Call and Participation in Upcoming Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/prosomnus-announces-q1-2023-investor-call-and-participation-in-upcoming-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"ProSomnus Announces Q1 2023 Investor Call and Participation in Upcoming Investor Conferences - Market Newsdesk","og_description":"PLEASANTON, Calif., April 26, 2023 (GLOBE NEWSWIRE) &#8212; ProSomnus, Inc.\u00a0(\u201cthe Company\u201d) (NASDAQ:\u00a0OSA), a pioneer in precision medical devices for the treatment of Obstructive Sleep Apnea (OSA), will report its first quarter financial results after market close on Thursday, May 9, 2023. ProSomnus Chief Executive Officer,\u00a0Len Liptak, and Chief Financial Officer,\u00a0Brian Dow, will host a conference call that day at\u00a01:30 p.m. PT\u00a0\/\u00a04:30 p.m. ET\u00a0to discuss the reported results and provide a business update. Investor Call Dial-In Information Interested parties may register for the conference call using the following link: ProSomnus Q1 Earnings Registration Link. You may access the live webcast of the conference call by using the following link:\u00a0ProSomnus Q1 Earnings Call. The link will also be posted in the Investor &hellip; Continue reading \"ProSomnus Announces Q1 2023 Investor Call and Participation in Upcoming Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/prosomnus-announces-q1-2023-investor-call-and-participation-in-upcoming-investor-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2023-04-26T15:17:53+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyNTUzMCM1NTU3MTgzIzIyNDQ3MTE=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prosomnus-announces-q1-2023-investor-call-and-participation-in-upcoming-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prosomnus-announces-q1-2023-investor-call-and-participation-in-upcoming-investor-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"ProSomnus Announces Q1 2023 Investor Call and Participation in Upcoming Investor Conferences","datePublished":"2023-04-26T15:17:53+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prosomnus-announces-q1-2023-investor-call-and-participation-in-upcoming-investor-conferences\/"},"wordCount":480,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prosomnus-announces-q1-2023-investor-call-and-participation-in-upcoming-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyNTUzMCM1NTU3MTgzIzIyNDQ3MTE=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prosomnus-announces-q1-2023-investor-call-and-participation-in-upcoming-investor-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/prosomnus-announces-q1-2023-investor-call-and-participation-in-upcoming-investor-conferences\/","name":"ProSomnus Announces Q1 2023 Investor Call and Participation in Upcoming Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prosomnus-announces-q1-2023-investor-call-and-participation-in-upcoming-investor-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prosomnus-announces-q1-2023-investor-call-and-participation-in-upcoming-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyNTUzMCM1NTU3MTgzIzIyNDQ3MTE=","datePublished":"2023-04-26T15:17:53+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prosomnus-announces-q1-2023-investor-call-and-participation-in-upcoming-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/prosomnus-announces-q1-2023-investor-call-and-participation-in-upcoming-investor-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prosomnus-announces-q1-2023-investor-call-and-participation-in-upcoming-investor-conferences\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyNTUzMCM1NTU3MTgzIzIyNDQ3MTE=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyNTUzMCM1NTU3MTgzIzIyNDQ3MTE="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prosomnus-announces-q1-2023-investor-call-and-participation-in-upcoming-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"ProSomnus Announces Q1 2023 Investor Call and Participation in Upcoming Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/751454","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=751454"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/751454\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=751454"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=751454"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=751454"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}